Ultragenyx Pharmaceutical... (RARE)
Ultragenyx Pharmaceutical Max Pain By Strike
RARE trades at $31.82, 6.1% above the near-term max pain of $30 expiring Sep 19, 2025 (13 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($20-$35), signaling increased put positioning or downside protection. Key magnetic zone at 30 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Ultragenyx Pharmaceutical Max Pain By Expiry
Max pain for RARE shows a downward trend from 35 to 20, indicating bearish sentiment or hedging activity. The 53% spread signals divergent expectations across timeframes. Most levels below 31.82 may cap rallies. Strong magnetic level at 30 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 30 | -1.82 (-5.72%) |
| Oct 17, 2025 | 27.5 | -4.32 (-13.58%) |
| Nov 21, 2025 | 30 | -1.82 (-5.72%) |
| Dec 19, 2025 | 35 | 3.18 (9.99%) |
| Jan 16, 2026 | 30 | -1.82 (-5.72%) |
| Feb 20, 2026 | 27.5 | -4.32 (-13.58%) |
| Jan 15, 2027 | 20 | -11.82 (-37.15%) |